Showing results (601-610 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 9, 2011
Assessing QT interval prolongation and its associated risks with antipsychoticsJimmi Nielsen, Claus Graff, Jørgen K Kanters, et al.CNS Drugs|June 25, 2011
Pharmacological management of treatment-resistant obsessive-compulsive disorderAnat Abudy, Alzbeta Juven-Wetzler, Joseph ZoharCNS Drugs|June 25, 2011
Issues in the management of challenging behaviours of adults with autism spectrum disorderJohnny L Matson, Megan Sipes, Jill C Fodstad, et al.CNS Drugs|August 5, 2015
Sphingosine 1-phosphate receptor modulators in multiple sclerosisAdnan M Subei, Jeffrey A CohenCNS Drugs|January 29, 2016
Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved ClarityMark Zimmerman, Matthew Multach, Emily Walsh, et al.CNS Drugs|November 21, 2015
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational StudiesTanja Tran, James M Brophy, Samy Suissa, et al.CNS Drugs|January 11, 2016
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewThomas M Gates, Lucette A CysiqueCNS Drugs|January 14, 2016
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple SclerosisAndrew Chan, Jérôme de Seze, Manuel ComabellaCNS Drugs|January 16, 2016
Abuse Potential of Pregabalin: A Systematic ReviewOle Schjerning, Mary Rosenzweig, Anton Pottegård, et al.CNS Drugs|January 23, 2016
Novel Thrombolytics for Acute Ischemic Stroke: Challenges and OpportunitiesNicola Logallo, Christopher E Kvistad, Aliona Nacu, et al.Pageof 211